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Abstract
CFTR possesses a large cluster of strict dibasic consensus sites for phosphorylation by protein kinase A (PKA) in the R-
domain and an obligatory dependence on phosphorylation is a hallmark of CFTR Cl3 channel function. Removal of as
many as 11 of these sites reduces the conformational change in the R-domain and the degree of channel activation in
response to PKA. However, until recently a completely PKA-unresponsive CFTR variant has not been reported, leaving
open the possibility that the residual response may be mediated by associating ancillary phosphoproteins. We traced the
residual PKA-catalyzed 32P-labelling of the variant with 11 sites mutagenized (11SA) to distinct CNBr phosphopeptides
within the R-domain. Mutagenesis of 4 additional monobasic sites in these segments produced a 15SA variant in which Cl3
channel response to PKA was abolished. Therefore, it can be concluded that ancillary phosphoproteins do not contribute to
CFTR activation by PKA. Notably, however, the 15SA protein did exhibit a low level of constitutive channel activity not
dependent on PKA, which might have reflected a down-regulating effect of phosphorylation of one or two of the 15 sites as
suggested by others. However, this did not prove to be the case.
Since immature CFTR has been claimed to be active in the endoplasmic reticulum (ER), we also examined whether it can
be phosphorylated in cells and what influence if any this might have on its susceptibility to degradation. Teleologically,
activation by phosphorylation of CFTR Cl3 channels in the ER might be undesirable to the cell. Using various
phosphorylation site mutants and kinase and phosphatase inhibitors in pulse-chase experiments, we have found that
although nascent CFTR can be phosphorylated at the ER, this is without effect on its ability to mature and avoid proteolysis.
Furthermore, we found that microsomes from cells expressing CFTR processing mutants such as vF508 do not generate Cl3
active channels when fused with planar bilayers unless maturation is promoted, e.g. by growth of cells at reduced temperature
or other means. We conclude that the ER-retained mutant nascent chains which are incapable of maturation may be
phosphorylated but do not form active channels. Stimulation by PKA of the insertion of CFTR containing vesicles into the
plasma membrane as part of the mechanism of stimulation of chloride secretion has been reported, as has an influence of
CFTR on the balance between endocytosis and exocytosis but these findings have not been universally confirmed. ß 1999
Elsevier Science B.V. All rights reserved.
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1. Introduction
CFTR is unique among ABC proteins in several
respects. First, it is the only one known to be itself
an ion channel. Second, its ion channel activity is
controlled by its phosphorylation state [1]. Although
several other ABC transporters are substrates for
phosphorylation by protein kinases, their primary
functions do not seem to be dependent on their phos-
phorylation state. In contrast, under ordinary cir-
cumstances, the CFTR ion channel activity has an
obligatory dependence on phosphorylation by cyclic
AMP-dependent protein kinase (PKA). Indeed the
response of CFTR to the action of PKA is the means
by which hormonal stimulation of epithelial chloride
secretion is mediated following elevation of cellular
cAMP. Opening of the apical CFTR channel allows
the cellular chloride concentration to fall, a change
which is sensed by the sodium, potassium, 2 chloride
co-transporter on the opposite, basolateral side of
the cell [2]. These three ions thereby enter the cell
from the blood side. Sodium ions are actively trans-
ported out again on the same side by the Na/K ATP-
ase and potassium ions passively move out through a
channel also in the basolateral membrane. The more
negative luminal transepithelial potential caused by
Cl3 exit through the CFTR channel promotes Na
passage from blood through a paracellular pathway
to lumen to complete this active secondary transport
of NaCl [3]. This overall process was postulated and
supported experimentally long before CFTR was dis-
covered [4]. However, considerable data has been
collected during the past decade indicating that
CFTR provides the primary regulatory step in this
transcellular routing of salt. CFTR also provides the
apical conduit for chloride ions in several salt reab-
sorbing epithelia as best exempli¢ed by the sweat
duct [5]. In addition to PKA, CFTR also can be
phosphorylated by several other protein kinases in-
cluding protein kinase C, casein kinase II, cyclic
GMP activated protein kinase, src kinase and possi-
bly others. With the exception of PKC, however,
which may in£uence the magnitude of the response
to PKA, the physiological signi¢cance on the action
of these other kinases on CFTR is unknown. The
nascent precursor of the mature CFTR chloride
channel can already be phosphorylated at the endo-
plasmic reticulum, an issue considered brie£y in this
article.
Although sites distributed throughout the cyto-
plasmic domains of CFTR may be phosphorylated,
most PKA sites are clustered in a large one in the
middle of the sequence.
2. Sites of phosphorylation
Initial inspection of the CFTR coding sequence
revealed a plethora of consensus sites for phosphor-
ylation by di¡erent kinases, especially PKA, PKC
and casein kinase II [6]. These are particularly con-
centrated in the exon 13 sequence of the CFTR gene
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which contains nine strict dibasic consensus sequen-
ces for phosphorylation by PKA (Fig. 1) and several
PKC sites. This region of the protein, termed the R-
domain, was originally de¢ned as the product of this
single large exon; its actual structural and functional
boundaries may vary considerably from those of
exon 13 although these serve rather well to delineate
the unusual concentration of PKA phosphorylation
sites which have been found to be responsible for the
tight control of channel activity. These sites were
especially notable because there was already evidence
of a defective cAMP-stimulated chloride conduc-
tance in CF epithelial cells [7]. Direct biochemical
evidence that several of these sites were phosphory-
lated by PKA came from phosphopeptide analysis of
a recombinant exon 13 produced in bacteria [8]. Ac-
tivation of CFTR chloride channels by addition of
the catalytic subunit of PKA to excised membrane
patches from CHO cells transfected with full-length
CFTR cDNA strongly suggested that direct phos-
phorylation of some of these sites might be respon-
sible [9]. To gain more evidence of this, substitution
of the serine residues at these sites with alanines by in
vitro mutagenesis was performed. Removal of any-
one of the nine dibasic R-domain sites individually
by this means did not signi¢cantly diminish cAMP
stimulated channel activity. However when multiple
sites were mutagenized at the same time, activity was
diminished. For example, simultaneous substitution
of alanines for serines at residues 660, 737, 795 and
813 caused a major reduction in forskolin stimulated
chloride e¥ux [10]. However, even when all nine di-
basic sites in the R-domain as well as a tenth site N-
terminal of NBD1 at residue 422 were mutagenized
(10SA mutant; [11]) substantial PKA stimulated
chloride channel activity remained.
To identify additional sites responsible for the re-
sponse still exhibited by 10SA, it was phosphorylated
with PKA using [Q-32P]ATP as substrate. Cyanogen
bromide digestion then yielded peptide fragments
that could be identi¢ed using site-speci¢c antibodies
and deletion constructs. Much of the radioactivity
localized to a CNBr fragment of V5.8 kDa corre-
sponding to a segment of the R-domain between res-
idues 722 and 773 [12]. This fragment contains six
serines of which two at positions 737 and 768 had
already been changed to alanines in the 10SA mu-
tant. The remaining four residues at positions 728,
742, 753, and 756 were individually substituted by
alanine in the 10SA background. The 5.8 kDa frag-
ment from all except the S753R version could still be
phosphorylated by PKA. When tested in both e¥ux
experiments and by patch-clamping the chloride
channel response to PKA of cells expressing 11SA-
S753R was reduced a further 40% compared to the
10SA.
However, two other CNBr fragments of the R-do-
main could still be labeled using [Q-32P]ATP, indicat-
ing additional residual phosphorylation. These se-
quences (segments 647^721, and 774^837) contain
three monobasic consensus sites for PKA phosphor-
ylation at residues S670, T690 and T787. Replace-
ment with alanine of these hydroxyl amino acids
Fig. 1. Comparison of the peptide substrate (kemptide) com-
monly used in PKA assays with dibasic consensus sequences in
CFTR; all except that at S422 are in the R-domain. Basic resi-
dues at positions 32 and 33 and hydrophobic residues at +1
with respect to the hydroxyl amino acids (highlighted) are
underlined.
Fig. 2. Schematic depiction of 15 sites mutated to produce a
PKA unresponsive CFTR (b) dibasic sites; E, O, monobasic
sites identi¢ed by phosphopeptide analysis.
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and a fourth one (S790) surrounded by several pos-
itively charged residues in the 11SA background
yielded a 155A variant (Fig. 2; [13]). Despite the
fact that it could still be weakly radiolabelled, no
channel activity was elicited by PKA. Hence the re-
moval of 15 PKA sites does render CFTR insensitive
to activation by the enzyme, indicating that the en-
tire PKA response may be mediated by direct phos-
phorylation of the protein without the need for in-
volvement of ancillary phosphoproteins.
The achievement of a PKA insensitive CFTR
channel by the removal of 15 sites implies that all
or most of these may be involved in activation. How-
ever, it is well established that di¡erent sites quanti-
tatively contribute very di¡erent proportions of the
response [1,11,12]. It has been suggested also that
di¡erent sites are qualitatively distinct such that
phosphorylation of one or one set of sites may result
in di¡erent channel gating properties than another
[14]. In this view, instead of serving to ensure or to
meter a single gated chloride permeability, the multi-
plicity of sites would generate channels with di¡erent
biophysical properties. It has been reported that dif-
ferent levels of phosphorylation cause di¡erent
modes of channel gating [15]. If indeed CFTR did
evolve di¡erent functional PKA phosphorylation
sites to accomplish diverse speci¢c channel character-
istics, it will be of great interest to learn the varied
physiological roles subserved by each.
One study reported that mutagenesis of two of the
dibasic sites, individually resulted in channels which
when expressed in Xenopus oocytes could be acti-
vated by lower concentrations of the phosphodiester-
ase inhibitor, IBMX than wild-type [16]. This appa-
rent increase in sensitivity to increased cAMP levels
was interpreted as meaning that phosphorylation at
either S737 or S768 diminished channel activation.
However, in another study, restoration of serine res-
idues at these two positions in the 15SA mutant re-
turned substantial CFTR single channel response to
PKA [13]. These di¡erent ¢ndings may mean that
phosphorylation at these two sites has quite di¡erent
e¡ects on the protein depending on whether the other
13 serines can be phosphorylated or not. Alterna-
tively, the di¡erences in expression systems, activat-
ing stimuli and assays of channel activity may ex-
plain the apparent di¡erence. If there are inhibitory
as well as stimulatory actions of PKA phosphoryla-
tion on the R-domain, the physiological signi¢cance
is not yet clear.
3. Mechanism of PKA activation
Since all of these sites except S422 are located in
the R-domain, it must be crucially involved in chan-
nel activation. The results of several types of experi-
ments are consistent with the idea that R-domain
phosphorylation by PKA relieves a constraint from
channel gating transitions which are driven by nu-
cleotide interactions with the other major cytoplas-
mic domains, the NBDs [17^21]. Thus gating transi-
tions cannot occur in the presence of MgATP
without R-domain phosphorylation [1], deletion of
the R-domain [17] or replacement of the hydroxyl
residues at PKA sites with carboxylate residues to
mimic the negative charges of the phosphoryl groups
[18]. Both of the latter manoeuvers however produce
only a minimal degree of constitutive activity. With
glutamate residues at eight of the nine dibasic sites in
the R-domain, the low spontaneous gating rates can
be increased to the same level as the wild-type by
phosphorylation with PKA. Thus while carboxylates
at the strong dibasic sites alone are only partially
e¡ective, they seem to contribute substantially when
combined with phosphorylation at other weaker
sites. Therefore it is reasonable to conclude that at
least part of the mechanism of channel activation by
R-domain phosphorylation is due to charge e¡ects.
Perhaps the increased negative charge disturbs other
charge interactions involved in keeping the channel
closed. There are many positively and negatively
charged residues in the cytoplasmic loops separating
the transmembrane sequences which contribute to
the ion pore as well as in the R-domain itself. Overall
the molecule has a very basic isoelectric point [22].
The introduction of multiple double negative charges
by the phosphorylation at many sites would lower
this appreciably, an e¡ect which could enable
NBD-controlled channel gating. It would also be
consistent with the need for phosphorylation at mul-
tiple sites rather than a single one for activation.
In addition to a passive negative e¡ect of an un-
phosphorylated R-domain, some experiments have
indicated a more active positive role of the phos-
phorylated domain [20]. This could help to ration-
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alize the fact that only partial activation is observed
when the domain is deleted [17]. The R-domain
undergoes signi¢cant secondary structure changes
which may be involved in the activation process on
phosphorylation by PKA (Fig. 3; [23]). While these
changes have been measured directly by circular di-
chroism only in an isolated recombinant R-domain
produced in bacteria, a major mobility shift of the
whole protein like that exhibited by the isolated do-
main occurs in SDS-PAGE on PKA catalyzed phos-
phorylation (Fig. 4). This shift is opposite in direc-
tion from that which would be due to addition of
negative charges and probably also re£ects a major
conformational change.
As already mentioned, R-domain phosphorylation
and dephosphorylation are not directly coupled to
channel gating transition but permit them to occur
as ATP interacts with the NBDs. Several authors
have suggested that PKA phosphorylation may in-
crease the a⁄nity of CFTR for ATP [24^26]. Exper-
imentally, support for the notion is largely at the
level of inverse correlations between the amount of
PKA phosphorylation or the number of sites phos-
phorylated and the ATP concentrations required for
channel activation [26]. Hence, while a⁄nity for ATP
may be altered this has not been directly measured
under appropriate conditions and it is also possible
that the molecular change coupling the binding event
to gating transitions is dependent on phosphoryla-
tion state. If this were the case, the relaying of the
impact of the nucleotide interactions with the NBDs
to channel opening and closing would be analogous
to the events believed to be responsible for transport
by other ABC proteins. In CFTR the coupling might
only occur when the restraining in£uence of the R-
domain is relieved by phosphorylation. As yet there
is only a single report of a small decrease in the Km
for ATP hydrolysis on PKA phosphorylation [25].
Hence it is still necessary to more extensively evalu-
ate the e¡ects of phosphorylation on direct measures
of ATP binding and hydrolysis as well as on poten-
tial conformational changes or alteration in domain
interactions. Such studies should reveal whether un-
phosphorylated and phosphorylated CFTR see ATP
di¡erently or see it in the same way but respond
di¡erently.
4. E¡ects of other kinases and protein phosphatases
While it seems clear that the action of PKA on
CFTR is the primary mediator of hormonal stimu-
lation of transepithelial chloride secretion, the mole-
cule is also in£uenced by protein kinase C [9,27] and
src kinase [28,29]). The major in£uence of PKC
Fig. 4. Calyculin A (+) causes shift in mobility of both mature
upper band and immature lower band of CFTR heterologously
expressed in CHO cells and endogenously expressed in intestinal
epithelial cell lines, T84 and CaCo2.
Fig. 3. Upper panels show large cathodic mobility shift caused
by PKA phosphorylation on a recombinant R-domain polypep-
tide. Replacement of serine residues at 8 dibasic sites with glu-
tamates (E) causes a partial shift not further in£uenced by
PKA. Lower panel shows change in circular dichroism spec-
trum on PKA phosphorylation of R-domain.
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seems to be to set the level of response to PKA
rather than to act as a primary activating modi¢ca-
tion [27]. Identi¢cation of the exact sites involved has
not yet been reported. Somewhat surprisingly, tyro-
sine phosphorylation by src kinase has also recently
been reported to activate CFTR channels [29]. It is
not yet clear, however, that this e¡ect is entirely due
to the phosphorylation of tyrosine residues on
CFTR, although that does occur.
The CFTR channel is maintained in a quiescent
state by phosphatase(s), some of which are mem-
brane-associated and possibly in a complex with
CFTR. In airway and colonic epithelial cells PP2C
may be primarily responsible for inactivation of
CFTR; PP2A or alkaline phosphatase are also able
to reduce channel activity dramatically when added
to membrane patches from CFTR expressing cells
[30^32]. Other phosphatases which have been tested
including PP1 and PP2B were found ine¡ective in
these kinds of experiments. It is not yet clear whether
or how the activity or accessibility of phosphatases
acting on CFTR may be regulated.
5. Role of phosphorylation in nascent CFTR turnover
During CFTR biogenesis, the conversion of the
immature nascent polypeptide already inserted in
the ER membrane matures ine⁄ciently and only
one quarter to one third of the molecules become
conformationally mature and competent to be ex-
ported from the ER, transported to the Golgi and
on to the cell surface [33]. The remainder of the
molecules are retained at the ER and degraded by
the cytosolic proteasome and other proteases [34,35].
At least one report has claimed that nascent CFTR
can generate a chloride channel in the ER membrane
[36]. Teleologically, one might imagine that activa-
tion of chloride conductance at this intracellular lo-
cation might be undesirable for the cell. Conceivably
the extreme susceptibility to proteolysis may help to
prevent this from happening. Nevertheless, a ¢nite
amount of immature CFTR must always be present
in the ER membrane to serve as the precursor of the
mature molecule. However, because the CFTR chan-
nel is so tightly regulated by phosphorylation, this
small population present at steady-state in the ER
membrane can be kept inactive as long as phospha-
tase activity exceeds that of PKA. As was shown in
Fig. 4, this apparently is the case because the gel
mobility shift re£ecting the PKA-driven conforma-
tional change in the immature as well as the mature
CFTR band is detected only when cells are treated
with a phosphatase inhibitor, such as calyculin A.
This indicates that indeed the nascent polypeptide
may be phosphorylated at the ER in intact cells
but that phosphatase activity normally keeps it in a
dephosphorylated state. Hence, it is reasonable to
think that rapid turnover and tonic phosphatase ac-
tivity may both act to minimize CFTR chloride
channel activity in the ER membrane.
Furthermore, it is of interest to ask if these two
deterrents to channel activity at this location are re-
lated; that is, might phosphorylation of nascent
CFTR contribute to its rapid turnover? This possi-
bility seems reasonable because nascent chains of
other ABC proteins not regulated by phosphoryla-
tion are not rapidly degraded in the ER. Further-
more, phosphorylation is a signal for ubiquitination
and proteasomal degradation of many other proteins
that need to be rapidly degraded to terminate their
functions [37]. If this was the case with nascent
CFTR, one might expect promotion of its phosphor-
ylation to accelerate turnover. However, increasing
its steady-state phosphorylation with calyculin A in
fact does the opposite; both disappearance of the
immature wild-type band and appearance of its ma-
ture product are inhibited (Fig. 5A). These e¡ects are
probably due to an inhibition by calyculin A of a
step in the secretory pathway rather than to in-
creased phosphorylation of nascent CFTR. This in-
terpretation is supported by the fact that the phos-
phatase inhibitor also slows the turnover of two
mutants in which the phosphorylation sites respon-
sible for the mobility shift have been removed (Fig.
5B and C). Independent of the action of the inhib-
itor, the fact that nascent chain turnover and forma-
tion of its mature product are the same with wild-
type and the 10SA variant (10 dibasic PKA sites
mutagenized; [11]) argues that phosphorylation state
is not a major determinant of nascent CFTR degra-
dation or maturation. Strictly speaking these conclu-
sions can be drawn from these observations only
with respect to phosphorylation at dibasic PKA
phosphorylation sites and those susceptible to caly-
culin A sensitive phosphatases. Since phosphatase(s)
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insensitive to this inhibitor such as PP2C contribute
to CFTR channel inactivation [31,32], it remains
possible that sites mediating these e¡ects might accel-
erate degradation. However, because deletion of
most of the R-domain (vR) or removal of all sites
involved in PKA activation (15SA) still is without
major in£uence on nascent CFTR processing this
may be unlikely. The possibility that phosphoryla-
tion at other sites by other kinases may in£uence
the fate of nascent CFTR has not been eliminated.
Aside from the issue of the potential channel ac-
tivity of wild-type nascent CFTR in the ER mem-
brane, it has been reported that the mutant vF508
CFTR nascent chain which never proceeds beyond
this location has chloride channel activity [38]. This
activity was detected by patch-clamping the ER
membrane surrounding isolated nuclei from cells het-
erologously expressing vF508 CFTR. We have iso-
lated microsomal membrane vesicles from similar
cells for assays of channel activity after fusion with
planar lipid bilayers. While wild-type CFTR chan-
nels are routinely recorded in this way [39], we failed
to detect activity with vesicles containing vF508
CFTR unless its maturation is ¢rst promoted by
growth of cells at reduced temperature or by mutat-
ing other sequences [40]. Hence, from these observa-
tions we conclude that nascent vF508 CFTR has the
potential to become active if its maturation is pro-
moted but that the misprocessed form normally
present at the ER is not activated by phosphoryla-
tion.
6. Role of phosphorylation in the distal secretory
pathway
Since increased cAMP stimulates exocytosis in sev-
eral cell types including some chloride secretory epi-
thelial cells, the possibility that CFTR may be in-
volved in mediating this e¡ect has been investigated
in several laboratories. CFTR was found to be
present in endosomes [41^43] and associated with
clathrin-coated vesicles [44]. Bradbury et al. [45] re-
ported that heterologous expression of wild-type
CFTR in a pancreatic ductal cell line caused in-
creased cAMP stimulated recycling and exocytosis
of wheat germ agglutinin which had been internal-
ized after binding to the cell surface. Endocytosis has
been found to be inhibited by cAMP agonists in
CFTR expressing cells and the protein itself probably
undergoes continuous recycling between the plasma
membrane and endocytotic vesicles [46]. However,
there is not convincing evidence that phosphoryla-
tion of CFTR by protein kinase A in£uences its dis-
tribution between these two pools nor the insertion
into or retrieval from the cell surface of these
vesicles. Nevertheless some authors have shown
that increased exposure of epitope-tagged CFTR at
the surface of Xenopus oocytes [47] and MDCK cells
[48] does occur on forskolin stimulation and sug-
gested that this may be at least a part of the mech-
anism of CFTR chloride channel activation.
Fig. 5. Pulse-chase experiments showing time courses of disap-
pearance of smaller immature precursor bands and appearance
of large mature products in absence (control) and presence of
calyculin A.
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7. Summary
The CFTR chloride channel is extremely tightly
regulated by its phosphorylation state. Addition of
varying numbers of phosphoryl groups at di¡erent
sites enables the channel to be gated by purine nu-
cleotides at concentrations normally present in the
cytoplasm. The level of activity is somewhat propor-
tional to the number of sites phosphorylated ena-
bling a metering of the chloride secretory response.
When not stimulated, phosphatases maintain, both
the mature cell surface protein and the immature
nascent form at the ER in an inactive dephosphory-
lated state. Phosphatase inhibition results in in-
creased steady-state phosphorylation of both. Phos-
phorylation of the nascent chain apparently does not
in£uence its turnover either by proteolysis or conver-
sion to mature protein. The vF508 nascent chain
does not normally form a chloride channel that can
be activated by phosphorylation but may do so if its
conformational maturation is promoted by arti¢cial
means. The insertion into and retrieval from the plas-
ma membrane of CFTR-containing vesicles may be
in£uenced by phosphorylation but not necessarily
that of CFTR.
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